2015-11-30 14:50:29 UTC

New Insights Into IBD Progression in Asia

Nov. 30, 2015

Gastro study finds that early course of disease in IBD patients in Asia is comparable with that of the West.

The incidence of IBD is increasing in Asia but little is known about disease progression in this region. A study published online in Gastroenterology sheds light on this topic, reporting that the early disease course for IBD in Asia can be as severe as in the West.

Siew C. Ng and colleagues present data on early disease outcomes from the Asia-Pacific Crohn’s and Colitis Epidemiology Study (ACCESS), which was initiated in 2011 to capture prospective incident IBD cases from nine countries in the Asia-Pacific region (China, Hong Kong, Indonesia, Sri Lanka, Macau, Malaysia, Singapore, Thailand and Australia).

The authors report in Gastroenterology that early disease severity, evolution and clinical outcomes of IBD in Asia are largely similar to that of the West, suggesting that health-care practices and associated costs seen in the West are likely to apply to Asia. These results may help to develop therapeutic strategies aimed at modifying the clinical course of IBD and provide clear and comprehensive information to patients about disease prognosis.

For additional insights into IBD in the Asia-Pacific region, including disease course, disease severity, risk factors for medical therapy and surgery, as well as cancer mortality rates, review the full study in Gastroenterology (login required).

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Feb. 7, 2019

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Best Practices in IBD: Differential Diagnosis

March 15, 2018

This activity outlines the different pathophysiologic processes and symptoms that differentiate IBD and from functional bowel disorders such as IBS, and it reviews AGA’s Crohn's disease and ulcerative colitis “Clinical Care Pathways.”